GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Interest Income

Endo (NDOI) Interest Income : $1 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Endo Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Endo's interest income for the three months ended in Dec. 2024 was $0 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2024 was $1 Mil.


Endo Interest Income Historical Data

The historical data trend for Endo's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Interest Income Chart

Endo Annual Data
Trend Dec22 Dec23 Dec24
Interest Income
- 0.99 -

Endo Quarterly Data
Jun23 Sep23 Dec23 Apr24 Sep24 Dec24
Interest Income Get a 7-Day Free Trial 0.19 0.49 0.40 0.17 -

Endo Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Endo Business Description

Traded in Other Exchanges
N/A
Address
9 Great Valley Parkway, Malvern, PA, USA, 19355
Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.